331 filings
Page 4 of 17
4
JSPR
Jasper Therapeutics Inc
8 Jun 23
Jasper Therapeutics / Vishal Kapoor ownership change
6:44pm
4
JSPR
Jasper Therapeutics Inc
8 Jun 23
Jasper Therapeutics / Lawrence Otto Klein ownership change
6:44pm
4
JSPR
Jasper Therapeutics Inc
8 Jun 23
Jasper Therapeutics / KURT VON EMSTER ownership change
6:43pm
4
Judith Anne Shizuru
8 Jun 23
Jasper Therapeutics / Judith Anne Shizuru ownership change
6:43pm
4
JSPR
Jasper Therapeutics Inc
8 Jun 23
Jasper Therapeutics / Chris Nolet ownership change
6:42pm
4
JSPR
Jasper Therapeutics Inc
8 Jun 23
Jasper Therapeutics / William Lis ownership change
6:42pm
4
Anna Louise French
8 Jun 23
Jasper Therapeutics / Anna Louise French ownership change
6:41pm
8-K
JSPR
Jasper Therapeutics Inc
8 Jun 23
Departure of Directors or Certain Officers
4:01pm
8-K
JSPR
Jasper Therapeutics Inc
2 Jun 23
Regulation FD Disclosure
5:03pm
10-Q
2023 Q1
JSPR
Jasper Therapeutics Inc
Quarterly report
12 May 23
4:10pm
8-K
JSPR
Jasper Therapeutics Inc
12 May 23
Jasper Therapeutics Reports First Quarter 2023 Financial Results and Provides a Business Update
4:05pm
EFFECT
JSPR
Jasper Therapeutics Inc
8 May 23
Notice of effectiveness
12:15am
424B5
JSPR
Jasper Therapeutics Inc
5 May 23
Prospectus supplement for primary offering
4:41pm
CORRESP
JSPR
Jasper Therapeutics Inc
3 May 23
Correspondence with SEC
12:00am
UPLOAD
JSPR
Jasper Therapeutics Inc
2 May 23
Letter from SEC
12:00am
S-3
JSPR
Jasper Therapeutics Inc
Shelf registration
28 Apr 23
4:00pm
ARS
2022 FY
JSPR
Jasper Therapeutics Inc
21 Apr 23
Annual report to shareholders
4:05pm
DEFA14A
JSPR
Jasper Therapeutics Inc
21 Apr 23
Additional proxy soliciting materials
4:03pm
DEF 14A
JSPR
Jasper Therapeutics Inc
Definitive proxy
21 Apr 23
4:01pm
144
Anna Louise French
14 Apr 23
Notice of proposed sale of securities
4:25pm